Corebridge Financial Declares Preferred Stock Dividend
Corebridge Financial, Inc. has declared a cash dividend of $34.375 per share on its 6.875% fixed rate reset non-cumulative preferred stock, Series A.
Stocks · News reference
UBS Maintains Neutral on Corebridge Financial, Raises Price Target to $36
UBS analyst Michael Ward maintains Corebridge Financial (NYSE:CRBG) with a Neutral and raises the price target from $32 to $36.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Corebridge (CRBG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Corebridge Financial reported Q3 2026 revenue of $4.5 billion, down 20.1% year-over-year and missing the consensus estimate of $4.78 billion by 5.83%. EPS matched expectations at $1.22, up from $0.96 in the prior year quarter. While premiums declined significantly by 72.3%, net investment income exceeded estimates at $3.23 billion, up 8.3% year-over-year. The stock holds a Zacks Rank #3 (Hold) rating.
Corebridge Financial Announces Third Quarter 2026 Results
Corebridge Financial reported its third quarter 2026 financial results, including net income of $1.4 billion and adjusted after-tax operating income of $545 million.
Wells Fargo Maintains Overweight on Corebridge Financial, Raises Price Target to $40
Wells Fargo analyst Wesley Carmichael maintains Corebridge Financial (NYSE:CRBG) with a Overweight and raises the price target from $39 to $40.
Amazon To $310? Here Are 10 Top Analyst Forecasts For Monday
Analysts raised targets for CRBG, MTN, CRM and FSLR, while cutting targets for PVLA, SPOT and AMZN; CRM and FSLR were upgraded.
Piper Sandler Maintains Overweight on Corebridge Financial, Raises Price Target to $40
Piper Sandler analyst Paul Newsome maintains Corebridge Financial (NYSE:CRBG) with a Overweight and raises the price target from $38 to $40.